Abstract. Primary renal lymphoma (PRL) is a rare disease, with no more than 70 cases reported in the literature. The present study reports the case of a 70-year-old woman with PRL. The patient was asymptomatic, however, a mass on the right kidney was identified incidentally during routine physical examination. Computed tomography revealed a mass in the right kidney that was 3.6 cm in diameter. Subsequently, right nephrectomy was performed. The histological evaluation of the nephrectomy specimen showed diffuse large B-cell non-Hodgkin's lymphoma. The patient was treated with 6-8 cycles of a cyclophosphamide, epirubicin, vindesine and dexamethasone regimen. Follow-up examination performed after 2 months of treatment revealed no evidence of local recurrence. The present study also reviewed 49 cases of PRL that have been reported since 1989. It was found that a shorter survival time was experienced by patients with bilateral PRL (mean, 21 months) compared with unilateral PRL (mean, 68 months). A shorter survival time was also experienced by patients who were treated with chemotherapy only (mean, 15.8 months) compared with those who were treated with combination chemotherapy and surgery (mean, 49.4 months).
Introduction
Primary renal lymphoma (PRL) is defined as a non-Hodgkin's lymphoma (NHL) involving the kidney in the absence of primarily extrarenal lymphatic disease. PRL is rare, as the kidney is an extranodal organ and does not contain lymphatic tissue (1) . Therefore, the existence of a PRL has been continuously debated. In recent years, reports of PRL cases have confirmed the presence of the disease. PRL has been shown to account for 0.7% of all extranodal lymphomas in North America and 0.1% of all malignant lymphomas in Japan (2, 3) . No more than 70 cases of PRL have been reported in the literature and the majority are of NHL large B-cell type (4) . The precise cause of PRL remains unknown. It has been suggested that PRL originates from the renal capsule and infiltrates the renal parenchyma. Another explanation is that chronic inflammatory conditions of the kidney attract the infiltration of lymphoid cells and eventually evolve into lymphoma (5) .
PRL is often present on only one side of the kidney in adult patients, whereas it can be bilateral in pediatric patients (6, 7) . PRL lacks clear clinical manifestations and appears to be similar to renal cell carcinoma (RCC), renal abscess and other kidney tumor metastases. Patients with PRL may present with gross hematuria, acute/chronic kidney failure, and flank pain or weight loss. It has been suggested that flank pain is one of the most common symptoms of PRL (8) .
The diagnosis of PRL includes: i) The presence of a renal mass; ii) no evidence of extrarenal lymphomatous involvement in the visceral organs or lymph nodes at first admission; and iii) the absence of a leukemic blood picture together with no evidence of myelosuppression (9) . However, a kidney biopsy remains the gold standard for the diagnosis of primary renal lymphoma (10) .
PRL is difficult to diagnose by imaging alone due to its non-specific manifestations and can be roughly divided into multiple renal masses, solitary masses, renal invasion from contiguous retroperitoneal disease, perirenal disease and diffuse renal infiltration (11, 12) . PRL is shown as a low echo mass on ultrasound, and the use of enhanced computed tomography (CT) and magnetic resonance imaging (MRI) can improve the specificity of lymphoma. On CT scans, PRL generally presents as an isointense or low-density mass. On contrast-enhanced CT scans, PRL appears to be less dense than the adjacent renal parenchyma. On MRI, PRL exhibits a hypointense signal on T1-weighted images and an isointense to hypointense signal on T2-weighted images. PRL may also demonstrate restricted diffusion on diffusion-weighted imaging (13 (16, 17) . It has also been shown that PRL exhibits an area of intense fluorodeoxyglucose ( 18 F-FDG) uptake on 18 F-FDG positron emission tomography/CT (PET/CT) images. The standardized uptake value (SUV) of PRL (SUV mean , 6.37±2.28) is significantly higher than renal clear cell carcinoma (SUV mean , 2.58±0.62), however, it is similar to that of RCC and renal collecting duct carcinoma (SUV mean , 6.27±1.15) (18) . The use of combined 18 F-FDG PET/CT greatly contributes to the accurate diagnosis and timely treatment of PRL, even prior to the biopsy results being obtained. This can also be used for the evaluation of the chemotherapy effect and the follow-up for PRL (19) .
Chemotherapy is the most common treatment for PRL. This treatment generally includes 6-8 cycles of a cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone (CHOP) regimen, or on the basis of this aforementioned plan, is combined with rituxan for cluster of differentiation (CD)20-positive NHL, in order to improve the patient's survival time to 5 years. However, the prognosis of PRL remains largely unknown. The 1-year mortality rates of PRL can be as high as 75% (20) , the median survival time is only 8 months to 3 years, and the 5-year survival rate is only 40-50% (21) .
The present study reports the case of a 70-year-old woman with PRL and provides a literature review of 49 cases of PRL that have been reported since 1989. Written informed consent was obtained from the patient.
Case report
In July 2014, a 70-year-old woman, with a medical history of type 2 diabetes mellitus for 7 years and arterial hypertension for 10 years, presented to Ningbo Yin Zhou Hospital (Ningbo, China) due to the sonographic detection of a mass in the right kidney. The patient did not report any night sweats, fever or weight loss. The physical examination was unremarkable and there was no sign of either lymphadenopathy or hepatosplenomegaly. The laboratory results were as follows: White blood cells (WBC), 7.9x10 9 /l (normal range, 3.5-9.5x10 9 /l); hemoglobin, 124 g/l (normal range, 115-150 g/l); platelets, 209x10 9 /l (normal range, 125-350x10 9 /l); blood urea nitrogen, 4.94 mmol/l (normal range, 2.9-8.2 mmol/l); and creatinine, 40 µmol/l (normal range, 45-84 µmol/l). Urine routine tests were negative for proteins, red blood cells (RBC) 1 particle/µl (normal range, 0-5 particle/µl), WBC 7 particle/µl (normal range, 0-9 particle/µl) and bacteria 164 particle/µl (normal range, 0-75 particle/µl). CT (Fig. 1A) revealed a 3.6-cm mass of right kidney without associated hydronephrosis or ureteral obstruction. The patient then underwent contrast-enhanced CT of the abdomen (Fig. 1B) . The results showed that the mass of the right kidney exhibited continuous progressive enhancement, with a value of 100 HU in the corticomedullary phase. The mass was initially suspected to be a malignancy of the right kidney and subsequently, a right nephrectomy was performed. Tissue specimens were fixed with 10% formalin, embedded in paraffin and stained with hematoxylin and eosin. The histological evaluation of the nephrectomy specimen (Fig. 1C ) revealed diffuse proliferation of large Zhongshan Jinqiao Biological Technology Co., Ltd.). Next, a bone marrow biopsy was performed, which showed no morphological involvement of lymphoma (Fig. 1D) . The NHL was finally considered to be PRL, as the imaging and biopsy results confirmed that there was no sign of peripheral lymphadenopathy or hepatosplenomegaly. The patient was treated with 6-8 cycles of a CHOP regimen (a combination of 1 g cyclophosphamide on day 1, 80 mg epirubicin on day 1, 3 mg vindesine on day 1, and 10 mg dexamethasone on days 1-5) (1 cycle, 28 days) and has completed three courses of treatment to date. On a CT scan following the third course of treatment, the patient showed a complete response to the treatment and no major discomfort was reported. Follow-up examination performed after 2 months of treatment revealed no local recurrence of the lymphoma. Follow-up every 3 months is planned for the first 2 years after treatment, and every 6 months in subsequent years.
Discussion PRL is extremely rare and a thorough review of PRL cases has been largely lacking in the literature. The present study reviewed all 49 cases of PRL reported in the literature since 1989 (Table I) . A finding of diffuse large B-cell lymphoma is the most common pathological sign. Of all 49 cases, 30 were male, 18 were female and 1 had an unrecorded gender. There were more male patients than female patients, and the ratio was ~1.6:1. In addition, the site of PRL can be age-related. The literature review found that PRL generally appears to be bilateral in patients who are younger than 18 years old and Table I . Despite the lack of statistical significance, the combination of chemotherapy and surgery produced longer survival times than single chemotherapy treatment, and the combined treatments may greatly slow disease progression. However, early detection and effective treatment is required to improve the prognosis.
Our review of 49 reported cases of PRL revealed that a combination of chemotherapy and surgery resulted in longer survival times than chemotherapy treatment alone. Therefore, the present patient was treated with 6-8 cycles of CHOP following nephrectomy. However, the literature review had several limitations. Firstly, all follow up data was obtained from different cases and thus, follow-up durations differ. Secondly, the follow-up durations were reported using different units of time, therefore, the mean survival time was calculated in months. Thirdly, a number of studies did not report the patients last follow-up date. Thus, further studies are required regarding the prognosis of the disease. The early diagnosis of PRL requires identification of the high-risk population, vulnerable organs, symptoms and image results. Pathological diagnosis is important for an early diagnosis. Chemotherapy is the preferred treatment, but its combination with radiotherapy, surgery and other means should be considered for patients with younger ages or bilateral PRL.
In conclusion, the patient in the present study was diagnosed incidentally with a mass in the right kidney during a routine physical examination and exhibited no clinical symptoms. The mass was initially suspected as renal cell cancer and, subsequently right nephrectomy was performed. However, histological evaluation of the nephrectomy specimen indicated diffuse large B-cell NHL. The patient was treated with 6-8 cycles of the CHOP regimen. Follow-up examination performed after 2 months of treatment revealed no local recurrence of the lymphoma.
